[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9799, "open": 0.9768, "dayLow": 0.8713, "dayHigh": 1.0, "regularMarketPreviousClose": 0.9799, "regularMarketOpen": 0.9768, "regularMarketDayLow": 0.8713, "regularMarketDayHigh": 1.0, "payoutRatio": 0.0, "beta": 1.022, "trailingPE": 0.6845385, "forwardPE": -0.54262197, "volume": 497804, "regularMarketVolume": 497804, "averageVolume": 636793, "averageVolume10days": 970150, "averageDailyVolume10Day": 970150, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 11, "marketCap": 8961293, "fiftyTwoWeekLow": 0.87, "fiftyTwoWeekHigh": 6.89, "priceToSalesTrailing12Months": 23.896782, "fiftyDayAverage": 3.863, "twoHundredDayAverage": 2.73815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6525474, "profitMargins": 0.0, "floatShares": 8599460, "sharesOutstanding": 10070000, "sharesShort": 1172123, "sharesShortPriorMonth": 454207, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.1187, "heldPercentInsiders": 0.07205, "heldPercentInstitutions": 0.26650998, "shortRatio": 1.81, "shortPercentOfFloat": 0.1189, "impliedSharesOutstanding": 11088400, "bookValue": 1.516, "priceToBook": 0.58700526, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14234000, "trailingEps": 1.3, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 17.401, "enterpriseToEbitda": -0.444, "52WeekChange": -0.5, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.8899, "targetHighPrice": 6.0, "targetLowPrice": 3.6, "targetMeanPrice": 4.8, "targetMedianPrice": 4.8, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 7015000, "totalCashPerShare": 0.71, "ebitda": -14713000, "totalDebt": 4753000, "quickRatio": 1.492, "currentRatio": 1.759, "totalRevenue": 375000, "debtToEquity": 34.207, "revenuePerShare": 0.05, "returnOnAssets": -0.34907, "returnOnEquity": -1.23281, "grossProfits": 375000, "freeCashflow": 4950750, "operatingCashflow": -16092000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -22.095, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "shortName": "iBio, Inc.", "fiftyTwoWeekLowChangePercent": 0.02287359, "fiftyTwoWeekRange": "0.87 - 6.89", "fiftyTwoWeekHighChange": -6.0000997, "fiftyTwoWeekHighChangePercent": -0.87084174, "fiftyTwoWeekChangePercent": -50.0, "dividendDate": 1528675200, "earningsTimestamp": 1739221500, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.3, "epsForward": -1.64, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -0.5596855, "fiftyDayAverageChange": -2.9731, "fiftyDayAverageChangePercent": -0.769635, "twoHundredDayAverageChange": -1.8482499, "twoHundredDayAverageChangePercent": -0.67499954, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-03-04", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744934322, "regularMarketTime": 1744920000, "exchange": "NCM", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -9.1846075, "regularMarketPrice": 0.8899, "longName": "iBio, Inc. Common Stock", "postMarketChangePercent": 3.3824, "postMarketPrice": 0.92, "postMarketChange": 0.0301, "regularMarketChange": -0.089999974, "regularMarketDayRange": "0.8713 - 1.0", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 636793, "fiftyTwoWeekLowChange": 0.019900024, "marketState": "CLOSED", "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]